The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
Open accessAbstract
The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1. Mutation of ATM occurs in the human autosomal recessive disorder ataxia-telangiectasia, which is characterized by hypersensitivity to ionizing radiation and a failure of cells to arrest the cell cycle after the induction of DNA double-strand breaks. It has thus been proposed that ATM inhibition would cause cellular radio- and chemosensitization. Through screening a small molecule compound library developed for the phosphatidylinositol 3'-kinase-like kinase family, we identified an ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933), that inhibits ATM with an IC(50) of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translocation of USP10 could be blocked by the ATM inhibitor Ku55933”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Hickson et al., 2004
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,050
Research works printed but not linked: 1
- Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK
Cited by
Sorted by citations
Items 101–200 of 1,000
van Sluis, M., & McStay, B. (2015) · Genes & Development · doi:10.1101/gad.260703.115 · Cited by 254
Lafarga, V., Cuadrado, A., de Silanes, I. L., Bengoechea, R., Fernández-Capetillo, Ó., & Nebreda, Á. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00210-09 · Cited by 255
Vendetti, F. P., Lau, A., Schamus, S., Conrads, T. P., O’Connor, M. J., & Bakkenist, C. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6247 · Cited by 252
The structural determinants of checkpoint activation
MacDougall, C. A., Byun, T. S., Van, C., Yee, M.-C., & Cimprich, K. A. (2007) · Genes & Development · doi:10.1101/gad.1522607 · Cited by 240
Nikitin, P. A., Yan, C. M., Forte, E., Bocedi, A., Tourigny, J. P., White, R. E., Allday, M. J., Patel, A. B., Davé, S. S., Kim, W., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.004 · Cited by 234
CtIP Links DNA Double-Strand Break Sensing to Resection
You, Z., Shi, L. Z., Zhu, Q., Wu, P., Zhang, Y.-W., Basilio, A., Tonnu, N., Verma, I. M., Berns, M. W., & Hunter, T. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.002 · Cited by 231
Zhang, Q., Green, M. D., Lang, X., Lazarus, J., Parsels, J. D., Wei, S., Parsels, L. A., Shi, J., Ramnath, N., Wahl, D. R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0761 · Cited by 229
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Srivastava, M., & Raghavan, S. C. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.11.013 · Cited by 230
Foote, K. M., Blades, K., Cronin, A. S., Fillery, S. M., Guichard, S. S., Hassall, L. A., Hickson, I., Jacq, X., Jewsbury, P. J., McGuire, T. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301859s · Cited by 223
Self-citationThe emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer
Madhusudan, S., & Middleton, M. R. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.09.006 · Cited by 223
Sanli, T., Rashid, A., Liu, C., Harding, S. M., Bristow, R. G., Cutz, J.-C., Singh, G., Wright, J. R., & Tsakiridis, T. K. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.005 · Cited by 216
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Biddlestone-Thorpe, L., Sajjad, M., Rosenberg, E., Beckta, J. M., Valerie, N. C. K., Tokarz, M. E., Adams, B. R., Wagner, A. F., Khalil, A. A., Gilfor, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3408 · Cited by 219
Bryant, H. E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl108 · Cited by 212
Cremona, C. A., & Behrens, A. (2013) · Oncogene · doi:10.1038/onc.2013.275 · Cited by 219
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z. J., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 209
Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo
Pellegrini, M., Celeste, A., Difilippantonio, S., Guo, R., Wang, W., Feigenbaum, L., & Nussenzweig, A. (2006) · Nature · doi:10.1038/nature05112 · Cited by 209
Savic, V., Yin, B., Maas, N. L., Bredemeyer, A. L., Carpenter, A. C., Helmink, B. A., Yang-Iott, K. S., Sleckman, B. P., & Bassing, C. H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.012 · Cited by 204
Synthetic lethality: exploiting the addiction of cancer to DNA repair
Shaheen, M. F., Allen, C., Nickoloff, J. A., & Hromas, R. (2011) · Blood · doi:10.1182/blood-2011-01-313734 · Cited by 207
Rapid PIKK-Dependent Release of Chk1 from Chromatin Promotes the DNA-Damage Checkpoint Response
Smits, V. A. J., Reaper, P. M., & Jackson, S. P. (2005) · Current Biology · doi:10.1016/j.cub.2005.11.066 · Cited by 212
Self-citationEaton, J. S., Lin, Z. P., Sartorelli, A. C., Bonawitz, N. D., & Shadel, G. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31604 · Cited by 198
Gourley, C., Balmañà, J., Ledermann, J. A., Serra, V., Dent, R. A., Loibl, S., Pujade-Lauraine, É., & Boulton, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02050 · Cited by 195
The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair
Xu, Y., Sun, Y., Jiang, X., Ayrapetov, M. K., Moskwa, P., Yang, S., Weinstock, D. M., & Price, B. D. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001160 · Cited by 194
The Epidermal Growth Factor Receptor: A Role in Repair of Radiation-Induced DNA Damage
Chen, D. J., & Nirodi, C. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1610 · Cited by 197
Targeting ATR in DNA damage response and cancer therapeutics
Fokas, E., Prevo, R., Hammond, E. M., Brunner, T. B., McKenna, W. G., & Muschel, R. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.002 · Cited by 197
ATR-dependent radiation-induced γH2AX foci in bystander primary human astrocytes and glioma cells
Burdak‐Rothkamm, S., Short, S. C., Folkard, M., Rothkamm, K., & Prise, K. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209863 · Cited by 190
Golding, S. E., Rosenberg, E., Neill, S. J., Dent, P., Povirk, L. F., & Valerie, K. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2371 · Cited by 190
Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR
Winter, M., Sombroek, D., Dauth, I., Moehlenbrink, J., Scheuermann, K., Crone, J., & Hofmann, T. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1743 · Cited by 194
Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
Bolderson, E., Richard, D. J., Zhou, B. S., & Khanna, K. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0096 · Cited by 194
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 189
Balmus, G., Pilger, D., Coates, J., Demir, M., Sczaniecka-Clift, M., Barros, A. C., Woods, M., Fu, B., Yang, F., Chen, E. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07729-2 · Cited by 195
Self-citationPhosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death
Tian, B., Yang, Q., & Mao, Z. (2009) · Nature Cell Biology · doi:10.1038/ncb1829 · Cited by 184
Chemical screening identifies ATM as a target for alleviating senescence
Kang, H. T., Park, J. T., Choi, K., Kim, Y., Choi, H. J. C., Jung, C. W., Lee, Y.-S., & Park, S. C. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2342 · Cited by 184
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
Sishc, B. J., & Davis, A. J. (2017) · Cancers · doi:10.3390/cancers9070081 · Cited by 178
Kiziltepe, T., Hideshima, T., Catley, L. P., Raje, N. S., Yasui, H., Shiraishi, N., Okawa, Y., Ikeda, H., Vallet, S., Pozzi, S., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0010 · Cited by 185
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Hsu, C.-H., Altschuler, S. J., & Wu, L. F. (2019) · Cell · doi:10.1016/j.cell.2019.05.041 · Cited by 181
The DNA Damaging Revolution: PARP Inhibitors and Beyond
Yap, T. A., Plummer, R., Azad, N. S., & Helleday, T. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238473 · Cited by 178
Current concepts in clinical radiation oncology
Orth, M., Lauber, K., Niyazi, M., Friedl, A. A., Li, M., Maihöfer, C., Schüttrumpf, L., Ernst, A., Niemoeller, O. M., & Belka, C. (2013) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0497-2 · Cited by 187
Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy
Wang, Y., Ji, P., Liu, J., Broaddus, R. R., Xue, F., & Zhang, W. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-8 · Cited by 179
DNA repair deficiency as a therapeutic target in cancer
Martin, S. A., Lord, C. J., & Ashworth, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.016 · Cited by 176
Kennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., la Vega, M. A. D., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 178
Checkpoint Responses to DNA Double-Strand Breaks
Waterman, D. P., Haber, J. E., & Smolka, M. B. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011520-104722 · Cited by 184
Mukherjee, B., Tomimatsu, N., Amancherla, K. V., Camacho, C. V., Pichamoorthy, N., & Burma, S. (2012) · Neoplasia · doi:10.1593/neo.111512 · Cited by 173
DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy
Carrassa, L., & Damia, G. L. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.013 · Cited by 178
Batey, M. A., Zhao, Y., Kyle, S., Richardson, C. J., Slade, A., Martin, N. M. B., Lau, A., Newell, D. R., & Curtin, N. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0707 · Cited by 167
Self-citationRiches, L. C., Trinidad, A. G., Hughes, G., Jones, G. N., Hughes, A. M., Thomason, A. G., Gavine, P. R., Cui, A., Ling, S., Stott, J., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1394 · Cited by 168
Self-citationKAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling
Kaidi, A., & Jackson, S. P. (2013) · Nature · doi:10.1038/nature12201 · Cited by 167
Self-citationRetractedATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165
Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
Xu, Y., & Her, C. (2015) · Biomolecules · doi:10.3390/biom5031652 · Cited by 169
Adams, K. E., Medhurst, A. L., Dart, D. A., & Lakin, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209426 · Cited by 164
Richard, J., Sindhu, S. T. A. K., Pham, T. N. Q., Belzile, J.-P., & Cohen, É. A. (2009) · Blood · doi:10.1182/blood-2009-08-237370 · Cited by 162
Targeting the DNA Damage Response in Cancer
Ljungman, M. E. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 164
Andrš, M., Korábečný, J., Jun, D., Hodný, Z., Bártek, J., & Kuča, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501026z · Cited by 164
Nguyen, H. D., Leong, W. Y., Li, W., Reddy, P. N. G., Sullivan, J. D., Walter, M. J., Zou, L., & Graubert, T. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3970 · Cited by 169
A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1
Blasius, M., Forment, J. V., Thakkar, N., Wagner, S., Choudhary, C., & Jackson, S. P. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r78 · Cited by 165
Self-citationMarshall, C. H., Sokolova, A. O., McNatty, A. L., Cheng, H. H., Eisenberger, M. A., Bryce, A. H., Schweizer, M. T., & Antonarakis, E. S. (2019) · European Urology · doi:10.1016/j.eururo.2019.02.002 · Cited by 162
Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase
Lau, A., Swinbank, K. M., Ahmed, P. S., Taylor, D. L., Jackson, S. P., Smith, G. C. M., & O’Connor, M. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1250 · Cited by 157
Self-citationKatyal, S., Lee, Y., Nitiss, K. C., Downing, S. M., Li, Y., Shimada, M., Zhao, J., Russell, H. R., Petrini, J. H. J., Nitiss, J. L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3715 · Cited by 152
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA‐PK
Das, B. B., Antony, S., Gupta, S., Dexheimer, T. S., Redon, C. E., Garfield, S., Shiloh, Y., & Pommier, Y. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.302 · Cited by 151
Davalli, P., Marverti, G., Lauriola, A., & D’Arca, D. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2389523 · Cited by 156
Powley, I. R., Kondrashov, A. V., Young, L. A., Dobbyn, H. C., Hill, K., Cannell, I. G., Stoneley, M., Kong, Y. W., Cotes, J. A., Smith, G. C. M., et al. (2009) · Genes & Development · doi:10.1101/gad.516509 · Cited by 158
Self-citationRetractedDNA-Damage Response during Mitosis Induces Whole-Chromosome Missegregation
Bakhoum, S. F. W., Kabeche, L., Murnane, J. P., Zaki, B. I., & Compton, D. A. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0403 · Cited by 146
Macůrek, L., Lindqvist, A., Voets, O., Kool, J., Vos, H. R., & Medema, R. H. (2010) · Oncogene · doi:10.1038/onc.2009.501 · Cited by 153
Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 152
Anderson, R. M., Bosch, J. A., Goll, M. G., Hesselson, D., Dong, P. D. S., Shin, D., Chi, N. C., Shin, C. H., Schlegel, A., Halpern, M. E., et al. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.07.017 · Cited by 146
Zhang, Y., Jones, T. L., Martin, S. E., Caplen, N. J., & Pommier, Y. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003020 · Cited by 147
Tejera, Á. M., d’Alcontres, M. S., Thanasoula, M., Marión, R. M., Martínez, P., Liao, C., Flores, J. M., Tarsounas, M., & Blasco, M. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.011 · Cited by 157
Targeted cancer therapies based on the inhibition of DNA strand break repair
O’Connor, M. J., Martin, N. M. B., & Smith, G. C. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210879 · Cited by 147
Self-citationLinking hypoxia, DNA damage and proliferation in multicellular tumor spheroids
Riffle, S., Pandey, R. N., Albert, M., & Hegde, R. S. (2017) · BMC Cancer · doi:10.1186/s12885-017-3319-0 · Cited by 142
Momčilović, O., Choi, S., Varum, S., Bakkenist, C. J., Schatten, G. P., & Navara, C. S. (2009) · Stem Cells · doi:10.1002/stem.123 · Cited by 142
ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres
Tong, A. S., Stern, J. L., Sfeir, A. J., Kartawinata, M., de Lange, T., Zhu, X., & Bryan, T. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.041 · Cited by 138
Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks
Chanut, P., Britton, S., Coates, J., Jackson, S. P., & Calsou, P. (2016) · Nature Communications · doi:10.1038/ncomms12889 · Cited by 162
Self-citationATR and Chk1 Suppress a Caspase-3–Dependent Apoptotic Response Following DNA Replication Stress
Myers, K. N., Gagou, M. E., Zuazua‐Villar, P., Rodríguez, R., & Meuth, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000324 · Cited by 146
Reinson, T., Toots, M., Kadaja, M., Pipitch, R., Allik, M., Ustav, E., & Ustav, M. (2012) · Journal of Virology · doi:10.1128/jvi.01943-12 · Cited by 141
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
Shimura, T., Kakuda, S., Ochiai, Y., Nakagawa, H., Kuwahara, Y., Takai, Y., Kobayashi, J., Komatsu, K., & Fukumoto, M. (2010) · Oncogene · doi:10.1038/onc.2010.238 · Cited by 143
Lu, X., Mattis, V. B., Wang, N., Al‐Ramahi, I., van den Berg, N., Fratantoni, S. A., Waldvogel, H. J., Greiner, E. R., Osmand, A., Merz, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010523 · Cited by 142
Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
Minchom, A. R., Aversa, C., & Lopez, J. S. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918786658 · Cited by 138
The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?
Goehe, R. W., Di, X. M., Sharma, K., Bristol, M. L., Henderson, S. C., Valerie, K. C., Rodier, F., Davalos, A. R., & Gewirtz, D. A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197590 · Cited by 144
Function of a Conserved Checkpoint Recruitment Domain in ATRIP Proteins
Ball, H. L., Ehrhardt, M. R., Mordes, D. A., Glick, G. G., Chazin, W., & Cortez, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02238-06 · Cited by 143
DNA-PKcs and ATM co-regulate DNA double-strand break repair
Shrivastav, M., Miller, C. A., Haro, L. P. D., Durant, S. T., Chen, B. P. C., Chen, D. J., & Nickoloff, J. A. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.05.006 · Cited by 145
Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
Biau, J., Chautard, E., Verrelle, P., & Dutreix, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01009 · Cited by 147
Reynolds, P., Anderson, J. A., Harper, J. V., Hill, M. A., Botchway, S. W., Parker, A. W., & O’Neill, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks879 · Cited by 134
Radiation-induced DNA damage and repair effects on 3D genome organization
Sanders, J. T., Freeman, T. F., Xu, Y., Golloshi, R., Stallard, M. A., Hill, A. M., San Martin, R., Balajee, A. S., & McCord, R. P. (2020) · Nature Communications · doi:10.1038/s41467-020-20047-w · Cited by 134
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W., & McArthur, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.358 · Cited by 133
Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability
Kumareswaran, R., Ludkovski, O., Meng, A. X., Sykes, J. R., Pintilie, M., & Bristow, R. G. (2012) · Journal of Cell Science · doi:10.1242/jcs.092262 · Cited by 130
Phase Resetting of the Mammalian Circadian Clock by DNA Damage
Oklejewicz, M., Destici, E., Tamanini, F., Hut, R. A., Janssens, R. C., & van der Horst, G. T. J. (2008) · Current Biology · doi:10.1016/j.cub.2008.01.047 · Cited by 132
Halaby, M., Hibma, J. C., He, J., & Yang, D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.04.011 · Cited by 137
Pike, K. G., Barlaam, B. C., Cadogan, E. B., Campbell, A. D., Chen, Y., Colclough, N., Davies, N. L., de-Almeida, C., Degorce, S. L., Didelot, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01896 · Cited by 135
Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2795 · Cited by 131
Activation of DSB Processing Requires Phosphorylation of CtIP by ATR
Peterson, S., Li, Y., Wu-Baer, F., Chait, B. T., Baer, R. J., Yan, H., Gottesman, M. E., & Gautier, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.020 · Cited by 137
Jazayeri, A. R., Balestrini, A., Garner, E., Haber, J. E., & Costanzo, V. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.128 · Cited by 141
ATR and H2AX cooperate in maintaining genome stability under replication stress
Chanoux, R. A., Yin, B., Urtishak, K. A., Asare, A., Bassing, C. H., & Brown, E. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806739200 · Cited by 130
Telomere Loop Dynamics in Chromosome End Protection
Ly, D. V., Low, R. R. J., Frölich, S., Bartolec, T. K., Kafer, G. R., Pickett, H. A., Gaus, K., & Cesare, A. J. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.025 · Cited by 134
Nam, E. A., Zhao, R., Glick, G. G., Bansbach, C. E., Friedman, D. B., & Cortez, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248914 · Cited by 129
Chemically targeting the PI3K family
Knight, Z. A., & Shokat, K. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350245 · Cited by 125
Pettersen, H. S., Visnes, T., Vågbø, C. B., Svaasand, E. K., Doseth, B., Slupphaug, G., Kavli, B., & Krokan, H. E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr563 · Cited by 128
MRN, CtIP, and BRCA1 mediate repair of topoisomerase II–DNA adducts
Aparicio, T., Baer, R. J., Gottesman, M. E., & Gautier, J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201504005 · Cited by 128
Yin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 135
Structures of closed and open conformations of dimeric human ATM
Baretić, D., Pollard, H., Fisher, D. I., Johnson, C. M., Santhanam, B., Truman, C., Kouba, T., Fersht, A. R., Phillips, C., & Williams, R. L. (2017) · Science Advances · doi:10.1126/sciadv.1700933 · Cited by 132
Cell death during crisis is mediated by mitotic telomere deprotection
Hayashi, M. T., Cesare, A. J., Rivera, T., & Karlseder, J. (2015) · Nature · doi:10.1038/nature14513 · Cited by 125
Metadata
- Authors
- Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M.
- Affiliations
- 1KuDOS Pharmaceuticals Ltd., Cambridge Science Park, Milton Road, Cambridge;
- Newcastle University (GB)
- University of Cambridge (GB)
- ORCID
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9152-9159
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2101988823
- Cited by
- 1,220
- References
- 58
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 38 · 2023: 49 · 2022: 31 · 2021: 32 · 2020: 53 · 2019: 55 · 2018: 48 · 2017: 66 · 2016: 71 · 2015: 76 · 2014: 70 · 2013: 62 · 2012: 92
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, KU55933, kinase inhibitors, ataxia telangiectasia, radiosensitivity, DNA double-strand breaks, cell cycle arrest, p53 phosphorylation, NBS1, radiosensitization, chemosensitization, etoposide, doxorubicin, camptothecin, γH2AX, SMC1A
- MeSH terms
- Cell Cycle, Chromones, DNA-Binding Proteins, HeLa Cells, Humans, Kinetics, Morpholines, Phosphorylation, Pyrones, Radiation-Sensitizing Agents, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Inhibitory Concentration 50, Combinatorial Chemistry Techniques, Tumor Suppressor Proteins, Cell Line, Tumor, Protein Kinase Inhibitors, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review